Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14925 | 741 | 36.4 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
4 | 4 | ENVIRONMENTAL SCIENCES//GEOSCIENCES, MULTIDISCIPLINARY//METEOROLOGY & ATMOSPHERIC SCIENCES | 1766162 |
184 | 3 | METALLOTHIONEIN//WILSONS DISEASE//CADMIUM | 56156 |
1113 | 2 | WILSONS DISEASE//METALLOTHIONEIN//ATP7B | 9713 |
14925 | 1 | DISULFIRAM//NEPICASTAT//DIETHYLDITHIOCARBAMATE | 741 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DISULFIRAM | authKW | 2358276 | 21% | 37% | 153 |
2 | NEPICASTAT | authKW | 293025 | 1% | 89% | 8 |
3 | DIETHYLDITHIOCARBAMATE | authKW | 227322 | 5% | 16% | 35 |
4 | S METHYL N N DIETHYLTHIOLCARBAMATE SULFOXIDE | authKW | 164828 | 1% | 100% | 4 |
5 | PYRROLIDINE DITHIOCARBAMATE | authKW | 163998 | 3% | 16% | 25 |
6 | CARBAMATHIONE | authKW | 109883 | 1% | 67% | 4 |
7 | DISULFIRAM METABOLISM | authKW | 82414 | 0% | 100% | 2 |
8 | LOCALISED DELIVERY | authKW | 82414 | 0% | 100% | 2 |
9 | N METHYLDITHIOCARBAMATE | authKW | 82414 | 0% | 100% | 2 |
10 | S METHYL N N DIETHYLDITHIOCARBAMATE SULFINE | authKW | 82414 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1792 | 30% | 0% | 222 |
2 | Toxicology | 1446 | 14% | 0% | 102 |
3 | Substance Abuse | 505 | 4% | 0% | 30 |
4 | Oncology | 259 | 12% | 0% | 86 |
5 | Biochemistry & Molecular Biology | 89 | 14% | 0% | 101 |
6 | Psychiatry | 86 | 5% | 0% | 37 |
7 | Chemistry, Medicinal | 76 | 4% | 0% | 28 |
8 | Immunology | 72 | 7% | 0% | 49 |
9 | Medicine, Research & Experimental | 66 | 5% | 0% | 35 |
10 | Neurosciences | 62 | 8% | 0% | 59 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANGIOGENESE MICROENVIRONN CANC | 41207 | 0% | 100% | 1 |
2 | ANM PHYSIOL GEN COMPARAT IMMUNOPHYSIOL | 41207 | 0% | 100% | 1 |
3 | ANTITUMOR DRUG | 41207 | 0% | 100% | 1 |
4 | BIOMED MASS SPE OMETRY FUNCT PROTE IL GUGG | 41207 | 0% | 100% | 1 |
5 | BIOMED SCICANC BIOL | 41207 | 0% | 100% | 1 |
6 | BMSFPF GUGGENHEIM C009B | 41207 | 0% | 100% | 1 |
7 | BREAST CANC BIOL PROGRAMHWCRC | 41207 | 0% | 100% | 1 |
8 | DEP RADIOL ONCOL | 41207 | 0% | 100% | 1 |
9 | DIENST INTENS ZORG | 41207 | 0% | 100% | 1 |
10 | EUROMEDITERRANEAN SCI TECHNOL | 41207 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 4553 | 2% | 1% | 15 |
2 | BIOCHEMICAL PHARMACOLOGY | 2848 | 5% | 0% | 36 |
3 | INTERNATIONAL JOURNAL OF IMMUNOTHERAPY | 1392 | 1% | 1% | 4 |
4 | CHEMICAL RESEARCH IN TOXICOLOGY | 1319 | 2% | 0% | 13 |
5 | TOXICOLOGICAL SCIENCES | 1197 | 2% | 0% | 12 |
6 | PHARMACOLOGY & TOXICOLOGY | 1105 | 1% | 0% | 8 |
7 | RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY | 870 | 1% | 0% | 7 |
8 | TOXICOLOGY AND APPLIED PHARMACOLOGY | 688 | 2% | 0% | 13 |
9 | EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION | 672 | 0% | 1% | 2 |
10 | ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 609 | 1% | 0% | 11 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | JIAO, Y , HANNAFON, BN , DING, WQ , (2016) DISULFIRAM'S ANTICANCER ACTIVITY: EVIDENCE AND MECHANISMS.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 16. ISSUE 11. P. 1378 -1384 | 53 | 65% | 0 |
2 | FILOSTO, M , TENTORIO, M , BROGLIO, L , BUZIO, S , LAZZARINI, C , PASOLINI, MP , COTELLI, MS , SCARPELLI, M , MANCUSO, M , CHOUB, A , ET AL (2008) DISULFIRAM NEUROPATHY: TWO CASES OF DISTAL AXONOPATHY.CLINICAL TOXICOLOGY. VOL. 46. ISSUE 4. P. 314 -316 | 21 | 91% | 12 |
3 | CVEK, B , DVORAK, Z , (2007) TARGETING OF NUCLEAR FACTOR-KAPPA B AND PROTEASOME BY DITHIOCARBAMATE COMPLEXES WITH METALS.CURRENT PHARMACEUTICAL DESIGN. VOL. 13. ISSUE 30. P. 3155-3167 | 74 | 23% | 73 |
4 | SKROTT, Z , CVEK, B , (2012) DIETHYLDITHIOCARBAMATE COMPLEX WITH COPPER: THE MECHANISM OF ACTION IN CANCER CELLS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 12. ISSUE 12. P. 1184 -1192 | 43 | 36% | 20 |
5 | TAWARI, PE , WANG, ZP , NAJLAH, M , TSANG, CW , KANNAPPAN, V , LIU, P , MCCONVILLE, C , HE, B , ARMESILLA, AL , WANG, WG , (2015) THE CYTOTOXIC MECHANISMS OF DISULFIRAM AND COPPER(II) IN CANCER CELLS.TOXICOLOGY RESEARCH. VOL. 4. ISSUE 6. P. 1439 -1442 | 16 | 89% | 0 |
6 | DUAN, LC , SHEN, HM , ZHAO, GQ , YANG, RX , CAI, XY , ZHANG, LJ , JIN, CG , HUANG, YC , (2014) INHIBITORY EFFECT OF DISULFIRAM/COPPER COMPLEX ON NON-SMALL CELL LUNG CANCER CELLS.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 446. ISSUE 4. P. 1010-1016 | 17 | 77% | 11 |
7 | ZHANG, L , JIANG, Y , JING, GH , TANG, YL , CHEN, X , YANG, D , ZHANG, Y , TANG, X , (2013) A NOVEL UPLC-ESI-MS/MS METHOD FOR THE QUANTITATION OF DISULFIRAM, ITS ROLE IN STABILIZED PLASMA AND ITS APPLICATION.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 937. ISSUE . P. 54-59 | 18 | 78% | 0 |
8 | CVEK, B , (2011) TARGETING MALIGNANCIES WITH DISULFIRAM (ANTABUSE): MULTIDRUG RESISTANCE, ANGIOGENESIS, AND PROTEASOME.CURRENT CANCER DRUG TARGETS. VOL. 11. ISSUE 3. P. 332-337 | 25 | 50% | 32 |
9 | DE LA GARZA, R , BUBAR, MJ , CARBONE, CL , MOELLER, FG , NEWTON, TF , ANASTASIO, NC , HARPER, TA , WARE, DL , FULLER, MA , HOLSTEIN, GJ , ET AL (2015) EVALUATION OF THE DOPAMINE BETA-HYDROXYLASE (D BETA H) INHIBITOR NEPICASTAT IN PARTICIPANTS WHO MEET CRITERIA FOR COCAINE USE DISORDER.PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. VOL. 59. ISSUE . P. 40 -48 | 23 | 48% | 1 |
10 | FASEHEE, H , DINARVAND, R , GHAVAMZADEH, A , ESFANDYARI-MANESH, M , MORADIAN, H , FAGHIHI, S , GHAFFARI, SH , (2016) DELIVERY OF DISULFIRAM INTO BREAST CANCER CELLS USING FOLATE-RECEPTOR-TARGETED PLGA-PEG NANOPARTICLES: IN VITRO AND IN VIVO INVESTIGATIONS.JOURNAL OF NANOBIOTECHNOLOGY. VOL. 14. ISSUE . P. - | 15 | 56% | 3 |
Classes with closest relation at Level 1 |